These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 11426495)

  • 1. Behcet's disease in a patient with chronic myelogenous leukemia under hydroxyurea treatment: a case report and review of the literature.
    Vaiopoulos G; Terpos E; Viniou N; Nodaros K; Rombos J; Loukopoulos D
    Am J Hematol; 2001 Jan; 66(1):57-8. PubMed ID: 11426495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behçet's disease induced by interferon therapy for chronic myelogenous leukemia.
    Segawa F; Shimizu Y; Saito E; Kinoshita M
    J Rheumatol; 1995 Jun; 22(6):1183-4. PubMed ID: 7674251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of large genital ulcer due to hydroxyurea treatment in a patient with chronic myeloid leukemia and Behcet's disease.
    Karincaoglu Y; Kaya E; Esrefoglu M; Aydogdu I
    Leuk Lymphoma; 2003 Jun; 44(6):1063-5. PubMed ID: 12854911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behçet's disease in patients with chronic myelogenous leukemia: possible role of interferon-alpha treatment in the occurrence of Behçet's symptoms.
    Budak-Alpdoğan T; Demirçay Z; Alpdoğan O; Direskeneli H; Ergun T; Bayik M; Akoğlu T
    Ann Hematol; 1997 Jan; 74(1):45-8. PubMed ID: 9031616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxyurea induced leg ulcers.
    Abhyankar D; Shende C; Saikia T; Advani SH
    J Assoc Physicians India; 2000 Sep; 48(9):926-7. PubMed ID: 11198798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bilateral leg ulcers with pathologic evidence of small vessel vasculitis by skin biopsy during hydroxyurea therapy of chronic myelogenous leukemia].
    Tomiyama J; Yano K; Uchino S; Ito T; Kudo H; Irimajiri J; Ohkubo H; Kanazawa A; Kawahara Y
    Rinsho Ketsueki; 1997 Mar; 38(3):231-3. PubMed ID: 9095664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversible leg ulcer due to hydroxyurea in a case of chronic myeloid leukemia.
    Tripathi AK; Ahmad R; Sawlani KK
    J Assoc Physicians India; 2003 Oct; 51():1014-5. PubMed ID: 14719596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chronic myelogenous leukemia with long-term hypoplasia induced by alpha-interferon and hydroxyurea].
    Motomura S; Sakai R; Tomita N; Fujimaki K; Hattori M; Fujisawa S; Mohri H; Takahashi N; Maruta A; Kodama F; Okubo T
    Rinsho Ketsueki; 1998 Apr; 39(4):302-7. PubMed ID: 9597898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pure red cell aplasia occurring during the course of chronic myelogenous leukemia].
    Yasuyama M; Kawauchi K; Takei K; Ogasawara T; Ohkawa S
    Rinsho Ketsueki; 2004 Jan; 45(1):66-71. PubMed ID: 14999937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bilateral ankle ulcers associated with hydroxyurea therapy for chronic myelogenous leukemia].
    Masuoka H; Kobayashi M; Kaito K; Yoshida M; Sekita T; Saeki A; Nishiwaki K; Shimada T; Ochiai S; Ootsubo H
    Rinsho Ketsueki; 1995 Feb; 36(2):156-8. PubMed ID: 7715088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perimalleolar ulcers in hydroxyurea treated patients with concomitant chronic venous disease: diagnostic pitfalls.
    Jain V; Gupta K; Nagpal N
    J Coll Physicians Surg Pak; 2005 Oct; 15(10):658-60. PubMed ID: 19810313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Myositis caused by hydroxyurea in a patient with chronic myelogenous leukemia].
    Ikeda K; Mita M; Ishibashi T; Shichishima T; Maruyama Y
    Rinsho Ketsueki; 1998 Sep; 39(9):676-9. PubMed ID: 9796402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-utility analysis of imatinib mesylate for the treatment of chronic myelogenous leukemia in the chronic phase.
    Warren E; Ward S; Gordois A; Scuffham P
    Clin Ther; 2004 Nov; 26(11):1924-33. PubMed ID: 15639704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the impact of imatinib mesylate therapy on the prognosis of patients with Philadelphia chromosome-positive chronic myelogenous leukemia treated with interferon-alpha regimens for early chronic phase.
    Kantarjian H; O'Brien S; Cortes J; Shan J; Giles F; Garcia-Manero G; Verstovsek S; Faderl S; Rios MB; Talpaz M
    Cancer; 2003 Oct; 98(7):1430-7. PubMed ID: 14508830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxyurea-induced fever in a patient with chronic myelogenous leukemia.
    Tsurumi H; Goto H; Hara T; Moriwaki H
    Int J Hematol; 2000 Oct; 72(3):386-7. PubMed ID: 11186000
    [No Abstract]   [Full Text] [Related]  

  • 16. [Anhidrosis during long-term hydroxyurea therapy in a patient with chronic myelogenous leukemia].
    Takagi K; Nakamura T; Misaki H; Ueda T
    Rinsho Ketsueki; 2000 Nov; 41(11):1214-9. PubMed ID: 11193442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of alpha interferon and hydroxyurea in late phase refractory myeloproliferative disease.
    Litam PP; Landaw SA; Zamkoff KW
    Haematologia (Budap); 1994; 26(2):87-90. PubMed ID: 7890266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombotic microangiopathy associated with alpha-interferon therapy for chronic myeloid leukaemia.
    Galesic K; Bozic B; Racic I; Scukanec-Spoljar M
    Nephrology (Carlton); 2006 Feb; 11(1):49-52. PubMed ID: 16509932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gangrene of the toes in a patient with chronic myelogenous leukemia after long-term hydroxyurea therapy.
    Leo E; Krämer A; Hochhaus A; Krasniqi F; Hehlmann R; Ho AD
    Ann Hematol; 2002 Aug; 81(8):467-9. PubMed ID: 12224005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chronic myelogenous leukemia following therapy for pineal germinoma].
    Noda M; Shoda T; Takimoto Y; Okita H
    Rinsho Ketsueki; 2004 Jan; 45(1):72-4. PubMed ID: 14999938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.